SE0100200D0 - New film coating - Google Patents

New film coating

Info

Publication number
SE0100200D0
SE0100200D0 SE0100200A SE0100200A SE0100200D0 SE 0100200 D0 SE0100200 D0 SE 0100200D0 SE 0100200 A SE0100200 A SE 0100200A SE 0100200 A SE0100200 A SE 0100200A SE 0100200 D0 SE0100200 D0 SE 0100200D0
Authority
SE
Sweden
Prior art keywords
film coating
film
core
coating composition
pharmaceutical
Prior art date
Application number
SE0100200A
Other languages
English (en)
Swedish (sv)
Inventor
Arne Hoelzer
Jan-Erik Loefroth
Staffan Schantz
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100200A priority Critical patent/SE0100200D0/xx
Publication of SE0100200D0 publication Critical patent/SE0100200D0/xx
Priority to BR0206515-0A priority patent/BR0206515A/pt
Priority to PCT/SE2002/000103 priority patent/WO2002058677A1/en
Priority to NZ526792A priority patent/NZ526792A/xx
Priority to KR1020037009573A priority patent/KR100874582B1/ko
Priority to HK04106220.5A priority patent/HK1063432B/xx
Priority to PT02715942T priority patent/PT1355635E/pt
Priority to DK02715942T priority patent/DK1355635T3/da
Priority to ES02715942T priority patent/ES2233804T3/es
Priority to US10/466,099 priority patent/US7959947B2/en
Priority to AU2002225573A priority patent/AU2002225573B2/en
Priority to EP02715942A priority patent/EP1355635B1/en
Priority to SI200230081T priority patent/SI1355635T1/xx
Priority to CA002433530A priority patent/CA2433530A1/en
Priority to DE60202351T priority patent/DE60202351T2/de
Priority to IL15662302A priority patent/IL156623A0/xx
Priority to JP2002559011A priority patent/JP4303471B2/ja
Priority to AT02715942T priority patent/ATE285229T1/de
Priority to CNB028040813A priority patent/CN1218692C/zh
Priority to MXPA03006419A priority patent/MXPA03006419A/es
Priority to DE20220901U priority patent/DE20220901U1/de
Priority to IL156623A priority patent/IL156623A/en
Priority to ZA200305457A priority patent/ZA200305457B/en
Priority to NO20033305A priority patent/NO20033305L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
  • Laminated Bodies (AREA)
SE0100200A 2001-01-24 2001-01-24 New film coating SE0100200D0 (sv)

Priority Applications (24)

Application Number Priority Date Filing Date Title
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating
DE20220901U DE20220901U1 (de) 2001-01-24 2002-01-22 Neuer Filmüberzug
AU2002225573A AU2002225573B2 (en) 2001-01-24 2002-01-22 New film coating
SI200230081T SI1355635T1 (en) 2001-01-24 2002-01-22 New film coating
NZ526792A NZ526792A (en) 2001-01-24 2002-01-22 Film coating composition for controlled release from pharmaceutical formulations
KR1020037009573A KR100874582B1 (ko) 2001-01-24 2002-01-22 신규 필름 코팅물
HK04106220.5A HK1063432B (en) 2001-01-24 2002-01-22 New film coating
PT02715942T PT1355635E (pt) 2001-01-24 2002-01-22 Novo revestimento de pelicula
DK02715942T DK1355635T3 (da) 2001-01-24 2002-01-22 Ny filmcoating
ES02715942T ES2233804T3 (es) 2001-01-24 2002-01-22 Nuevo revestimiento de pelicula.
US10/466,099 US7959947B2 (en) 2001-01-24 2002-01-22 Film coating
BR0206515-0A BR0206515A (pt) 2001-01-24 2002-01-22 Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula, e uma formulação
EP02715942A EP1355635B1 (en) 2001-01-24 2002-01-22 New film coating
PCT/SE2002/000103 WO2002058677A1 (en) 2001-01-24 2002-01-22 New film coating
CA002433530A CA2433530A1 (en) 2001-01-24 2002-01-22 New film coating
DE60202351T DE60202351T2 (de) 2001-01-24 2002-01-22 Neuer filmüberzug
IL15662302A IL156623A0 (en) 2001-01-24 2002-01-22 New film coating
JP2002559011A JP4303471B2 (ja) 2001-01-24 2002-01-22 新規フィルム・コーティング
AT02715942T ATE285229T1 (de) 2001-01-24 2002-01-22 Neuer filmüberzug
CNB028040813A CN1218692C (zh) 2001-01-24 2002-01-22 新型薄膜包衣
MXPA03006419A MXPA03006419A (es) 2001-01-24 2002-01-22 Nuevo recubrimiento de pelicula.
IL156623A IL156623A (en) 2001-01-24 2003-06-24 Coating of a thin layer
ZA200305457A ZA200305457B (en) 2001-01-24 2003-07-15 New film coating.
NO20033305A NO20033305L (no) 2001-01-24 2003-07-22 Nytt filmbelegg

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating

Publications (1)

Publication Number Publication Date
SE0100200D0 true SE0100200D0 (sv) 2001-01-24

Family

ID=20282714

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100200A SE0100200D0 (sv) 2001-01-24 2001-01-24 New film coating

Country Status (21)

Country Link
US (1) US7959947B2 (enExample)
EP (1) EP1355635B1 (enExample)
JP (1) JP4303471B2 (enExample)
KR (1) KR100874582B1 (enExample)
CN (1) CN1218692C (enExample)
AT (1) ATE285229T1 (enExample)
AU (1) AU2002225573B2 (enExample)
BR (1) BR0206515A (enExample)
CA (1) CA2433530A1 (enExample)
DE (2) DE60202351T2 (enExample)
DK (1) DK1355635T3 (enExample)
ES (1) ES2233804T3 (enExample)
IL (2) IL156623A0 (enExample)
MX (1) MXPA03006419A (enExample)
NO (1) NO20033305L (enExample)
NZ (1) NZ526792A (enExample)
PT (1) PT1355635E (enExample)
SE (1) SE0100200D0 (enExample)
SI (1) SI1355635T1 (enExample)
WO (1) WO2002058677A1 (enExample)
ZA (1) ZA200305457B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
ES2377729T3 (es) * 2002-02-21 2012-03-30 Valeant International (Barbados) Srl Formulaciones de liberación modificada de al menos una forma de tramadol
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
RU2372893C2 (ru) * 2003-10-31 2009-11-20 Хексал Аг Содержащий фармацевтический агент состав с покрытием
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
DE14172396T1 (de) 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
CN102369000A (zh) * 2009-01-09 2012-03-07 前进制药公司 包含一种或多种富马酸酯的药用组合物
CN109044985A (zh) 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
EP2844296B1 (en) * 2012-05-02 2019-03-13 Capsugel Belgium NV Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
MX2015010449A (es) 2013-02-13 2015-10-30 Evonik Roehm Gmbh Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
CN105085778B (zh) * 2014-04-22 2018-11-16 广东华润涂料有限公司 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用
RS62275B1 (sr) * 2015-03-03 2021-09-30 Saniona As Kombinovana formulacija tesofensina i metoprolola
MA45553A (fr) * 2016-06-30 2019-05-08 Beckman Coulter Inc Substrats chimioluminescents
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) * 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4916171A (en) * 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
EP0313845A1 (en) 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
JP2558396B2 (ja) 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
NZ526792A (en) 2004-12-24
CN1218692C (zh) 2005-09-14
WO2002058677A1 (en) 2002-08-01
JP4303471B2 (ja) 2009-07-29
ES2233804T3 (es) 2005-06-16
SI1355635T1 (en) 2005-06-30
MXPA03006419A (es) 2003-10-15
CA2433530A1 (en) 2002-08-01
US7959947B2 (en) 2011-06-14
AU2002225573B2 (en) 2006-09-07
DE20220901U1 (de) 2004-06-17
EP1355635A1 (en) 2003-10-29
ATE285229T1 (de) 2005-01-15
KR20030070122A (ko) 2003-08-27
HK1063432A1 (en) 2004-12-31
NO20033305D0 (no) 2003-07-22
DE60202351T2 (de) 2005-12-01
US20040058001A1 (en) 2004-03-25
ZA200305457B (en) 2004-10-15
IL156623A (en) 2007-12-03
BR0206515A (pt) 2004-02-17
IL156623A0 (en) 2004-01-04
DK1355635T3 (da) 2005-03-29
EP1355635B1 (en) 2004-12-22
NO20033305L (no) 2003-07-22
KR100874582B1 (ko) 2008-12-16
JP2004522741A (ja) 2004-07-29
PT1355635E (pt) 2005-04-29
DE60202351D1 (de) 2005-01-27
CN1487828A (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
NO20033305L (no) Nytt filmbelegg
WO2002072034A3 (en) Chronotherapeutic dosage forms
CA2290531A1 (en) Pharmaceutical formulation of omeprazole
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
NO20012222L (no) Farmasöytisk formulering innbefattende omeprazol
EP1803473A3 (en) Adhesive including medicament
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
ATE184196T1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
MY129350A (en) Aripiprazole oral solution
EP1690530A3 (en) Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
WO2003002136A3 (en) Stable formulation of modified glp-1
WO2005027843A3 (en) Chronotherapeutic dosage forms
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
NO20031409L (no) Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse
ATE286736T1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
BR0115206A (pt) Composições hidroliticamente instáveis
EP1245562A4 (en) ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
WO2003035043A3 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
AU2001274000A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
ATE262898T1 (de) Formulierung mit gesteuerter wirkstoffabgabe enthaltend bupropion-hci als wirkstoff
CA2440710A1 (en) Medicine of post-traumatic stress disorder
HUP0204150A3 (en) Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate, process for its preparation and pharmaceutical compositions containing the same
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof